Stocks › GKOS

GLAUKOS Corp

GKOS·NYSE·United States United States·USD
$237.31
-0.79 (-0.33%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
GKOS
GLAUKOS Corp · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
GKOSS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of GKOS by members of U.S. Congress · 0 on record

No congressional trades in GKOS on record.

Whale Activity

Position changes in GKOS reported for 2026-09-30 by 455 institutional filers
Increased: 138New: 88Held: 43Decreased: 133Closed: 33No prior filing: 20
  • Increased138
  • New88
  • Held43
  • Decreased133
  • Closed33
  • No prior filing20
FilerSharesValueChange
BlackRock, Inc.9.3M$1.53Bdecreased
Janus Henderson Group Ltd.4.6M$760.2M—
VANGUARD PORTFOLIO MANAGEMENT LLC3.3M$542.5Mdecreased
PRIMECAP MANAGEMENT CO/CA/3.1M$505.1Mincreased
FMR LLC2.9M$470.9Mincreased
VANGUARD CAPITAL MANAGEMENT LLC2.5M$418.2Mdecreased
STATE STREET CORP2.3M$379.7Mdecreased
MILLENNIUM MANAGEMENT LLC1.5M$239.7Mdecreased
GEODE CAPITAL MANAGEMENT, LLC1.4M$238.0Mdecreased
Invesco Ltd.1.2M$202.8Mincreased
GOLDMAN SACHS GROUP INC1.0M$168.4Mincreased
Capital World Investors1.0M$166.7Mdecreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by GKOS insiders, by quarter · Form 4
-500.0K-250.0K0250.0K500.0K2025 Q1: -25.6K2025 Q12025 Q2: 02025 Q22025 Q3: -5,6592025 Q32025 Q4: -24.7K2025 Q42026 Q1: -325.7K2026 Q12026 Q2: -44.9K2026 Q22026 Q3: -130.6K2026 Q32026 Q4: -289.2K2026 Q4

Recent Insider Transactions

1,134 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Burns Thomas WilliamCHAIRMAN & CEO · Director Sale −6,919 $243.02 $1.7M Nov 18, 2026 Form 4 ↗
Burns Thomas WilliamCHAIRMAN & CEO · Director Sale −5,421 $241.14 $1.3M Nov 18, 2026 Form 4 ↗
Burns Thomas WilliamCHAIRMAN & CEO · Director Sale −4,285 $235.46 $1.0M Nov 18, 2026 Form 4 ↗
Burns Thomas WilliamCHAIRMAN & CEO · Director Sale −40.5K $232.61 $9.4M Nov 18, 2026 Form 4 ↗
Burns Thomas WilliamCHAIRMAN & CEO · Director Sale −3,390 $242.46 $822K Nov 18, 2026 Form 4 ↗
Burns Thomas WilliamCHAIRMAN & CEO · Director Sale −25.6K $234.74 $6.0M Nov 18, 2026 Form 4 ↗
Burns Thomas WilliamCHAIRMAN & CEO · Director Sale −234 $245.90 $58K Nov 18, 2026 Form 4 ↗
Burns Thomas WilliamCHAIRMAN & CEO · Director Sale −21.6K $237.99 $5.1M Nov 18, 2026 Form 4 ↗
Burns Thomas WilliamCHAIRMAN & CEO · Director Sale −19.3K $233.78 $4.5M Nov 18, 2026 Form 4 ↗
Burns Thomas WilliamCHAIRMAN & CEO · Director Sale −15.7K $237.29 $3.7M Nov 18, 2026 Form 4 ↗
Burns Thomas WilliamCHAIRMAN & CEO · Director Sale −15.0K $244.18 $3.7M Nov 18, 2026 Form 4 ↗
Burns Thomas WilliamCHAIRMAN & CEO · Director Sale −10.9K $240.06 $2.6M Nov 18, 2026 Form 4 ↗
Burns Thomas WilliamCHAIRMAN & CEO · Director Sale −1,087 $245.31 $267K Nov 18, 2026 Form 4 ↗
Burns Thomas WilliamCHAIRMAN & CEO · Director Sale −10.1K $239.27 $2.4M Nov 18, 2026 Form 4 ↗
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER Sale −998 $243.91 $243K Nov 18, 2026 Form 4 ↗
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER Sale −826 $239.52 $198K Nov 18, 2026 Form 4 ↗
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER Sale −548 $235.50 $129K Nov 18, 2026 Form 4 ↗
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER Sale −494 $244.40 $121K Nov 18, 2026 Form 4 ↗
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER Sale −368 $242.67 $89K Nov 18, 2026 Form 4 ↗
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER Sale −3,209 $232.65 $747K Nov 18, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding GKOS · SEC Form N-PORT
FundSharesValue% of fundAs of
iShares Core S&P Small-Cap ETF
iShares Trust
3.5M$494.3M0.44%Jun 30, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
1.8M$247.9M0.01%Jun 30, 2026
iShares Russell 2000 ETF
iShares Trust
1.5M$206.9M0.25%Jun 30, 2026
VANGUARD CAPITAL OPPORTUNITY FUND
VANGUARD HORIZON FUNDS
1.5M$206.6M0.63%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
1.3M$178.9M0.09%Jun 30, 2026
PRIMECAP Odyssey Aggressive Growth Fund
PRIMECAP Odyssey Funds
1.0M$168.1M2.27%Jul 31, 2026
Janus Henderson Triton Fund
Janus Investment Fund
1.1M$147.9M2.49%Jun 30, 2026
SMALLCAP World Fund Inc989.1K$138.2M0.15%Jun 30, 2026
Fidelity Small Cap Index Fund
Fidelity Salem Street Trust
630.4K$105.1M0.31%Jul 31, 2026
VANGUARD SMALL-CAP GROWTH INDEX FUND
VANGUARD INDEX FUNDS
737.4K$103.1M0.22%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list GKOS's shares (CUSIP 377322102), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • JANUS HENDERSON GROUP Ltd.SCHEDULE 13G/A · passive (13G) · 4.6M shares7.9%
    Nov 16, 2026 · ↗
  • JANUS HENDERSON GROUP PLCSCHEDULE 13G/A · passive (13G) · 5.3M shares9.2%
    May 15, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming glaukos as client
$0$250K$500K$750K$1.0M2023 Q1: $20K2023 Q2: $20K2023 Q3: $20K2023 Q4: $20K20232024 Q1: $20K2024 Q2: $120K2024 Q3: $130K2024 Q4: $170K20242025 Q1: $85K2025 Q2: $90K2025 Q3: $90K2025 Q4: $100K20252026 Q1: $320K2026 Q2: $280K2026 Q3: $300K2026
  • THORN RUN PARTNERSGLAUKOS CORPORATION · 2026 Q3 · HCR, MMM, TAX$20K
    Filing ↗
  • THORN RUN PARTNERSGLAUKOS CORPORATION · 2026 Q3 · HCR, MMM, TAX$20K
    Filing ↗
  • GLAUKOS CORPORATIONGLAUKOS CORPORATION · 2026 Q3 · MMM$240K
    Filing ↗
  • JEFFREY J. KIMBELL & ASSOCIATES, INC.GLAUKOS CORPORATION (FKA AVEDRO, INC.) · 2026 Q3 · HCR, MMM$20K
    Filing ↗
  • JEFFREY J. KIMBELL & ASSOCIATES, INC.GLAUKOS CORPORATION (FKA AVEDRO, INC.) · 2026 Q2 · MMM, HCR$20K
    Filing ↗

Government Contracts

Federal awards to glaukos · USAspending
$21KAwarded · 2 contracts on record
  • Department of Veterans AffairsIDOSE TR 75MCG IMPLANT TRADE$0
    Feb 1, 2025 · ↗
  • Department of Veterans AffairsIDOSE TRAVOPROST 75MCG IMPLANT$21K
    Feb 1, 2026 · ↗

U.S. Patents

Recent USPTO applications naming GLAUKOS Corp

No USPTO patent applications found for GLAUKOS Corp.

Annual Financials

From GKOS's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$507.4M$383.5M$314.7M$282.9M$294.0M
Operating income-$199.6M-$122.4M-$128.7M-$82.3M-$32.9M
Net income-$187.7M-$146.4M-$134.7M-$99.2M-$49.6M
Diluted EPS-$3.28-$2.77-$2.78-$2.09-$1.07
Operating cash flow-$14.8M-$61.3M-$57.8M-$33.1M$24.7M
Cash and equivalents$90.8M$169.6M$93.5M$119.5M$100.7M
Total assets$893.5M$974.8M$940.4M$1.00B$1.05B
Total liabilities$237.3M$207.8M$478.6M$472.4M$462.5M
Shareholders' equity$656.2M$766.9M$461.8M$530.0M$587.2M

As GLAUKOS Corp tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 23, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in GKOS's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 7.01, 9.01Reg FD disclosureNov 6, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureOct 28, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 9.01Reg FD disclosureAug 3, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureJul 29, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteJun 3, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 9.01Reg FD disclosureMay 4, 2026
    EDGAR ↗

About GLAUKOS Corp

From SEC EDGAR company records
Industry (SIC 3841)Surgical & Medical Instruments & Apparatus
SectorHealthcare
HeadquartersALISO VIEJO, CA
IncorporatedDE